Title: Fibroblast growth factor-23 (FGF-23) as a prognostic marker for chronic kidney disease (CKD)
Abstract: Fibroblast growth factor-23 (FGF-23) as a prognostic marker for chronic kidney disease (CKD) FGF-23 protein levels could help predict prognosis in patients with CKD.In 3,879 patients with stage 2-4 CKD, higher FGF-23 plasma protein levels were associated with greater risk for end-stage renal disease (ESRD) and mortality (p<0.001).Next steps include determining whether greater FGF-23 levels are a surrogate biomarker or directly linked to the increased risk of ESRD and mortality in CKD patients.